Drug Enforcement Administration August 18, 2023 – Federal Register Recent Federal Regulation Documents

Schedules of Controlled Substances: Placement of Metonitazene in Schedule I
Document Number: 2023-17778
Type: Rule
Date: 2023-08-18
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final order, the Administrator of the Drug Enforcement Administration is permanently placing N,N-diethyl- 2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-a mine (metonitazene), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. This scheduling action discharges the United States' obligations under the Single Convention on Narcotic Drugs (1961). This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle metonitazene.
Ndubuisi J. Okafor, M.D.; Decision and Order
Document Number: 2023-17794
Type: Notice
Date: 2023-08-18
Agency: Drug Enforcement Administration, Department of Justice
William Tuong, M.D.; Decision and Order
Document Number: 2023-17793
Type: Notice
Date: 2023-08-18
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.